10 年
手机商铺
公司新闻/正文
611 人阅读发布时间:2022-04-15 17:01

P53是著名的细胞基因组卫士,也是一种重要的肿瘤抑制基因,自从P53基因于1979年被首次报道后,SCI收录的有关研究论文已达数万篇。目前,在人类各类肿瘤中P53突变率超过50%,是肿瘤中最常见的遗传学改变。这意味着该基因的改变在人类肿瘤的发生、发展以及诊断、治疗等方面具有重要意义。
博奥森精品P53抗体,每个产品开放20支试用申请,先到先得......
本次活动试用抗体
每个产品限20支试用装
| 靶标 | 编号 | 交叉反应 | 应用 |
| P53 | bsm-10841M | Hu | ELISA IHC |
| P53 protein (wt-p53) |
bs-0033R | Hu Mo Rat |
ELISA ICC |
| P53(wt-p53) (D2F7) |
bsm-2346M | Hu Mo | WB ELISA |
| phospho-P53 (Ser33) |
bs-3705R | Hu Mo | WB ELISA IHC ICC FC |
| phospho-P53 (Thr55) |
bs-5596R | Hu | ELISA ICC FC |
抗体数据展示
LOVO cell (Human)lysate at 30μg were subjected to SDS-PAGE followed by WB with bs-5596R (Anti-Thr55 phospho p53) at dilution of 1:1000 incubated at 4℃ overnight.

Colon carcinoma (Human, 1) and kidney (Mouse, 2) lysate at 40μg were subjected to SDS-PAGE followed by WB with bsm-2346M (Anti-p53-wt) at dilution of 1:5000 incubated at 4℃ overnight.
Anti-P53 protein(wt-p53) (bs-0033R)
